1877 Share Price Performance
Recent 1877 News & Updates
No updates
Shanghai Junshi Biosciences Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 27, 2025
- Earnings per share (EPS)
- -1.20
- Gross Margin
- 75.37%
- Net Profit Margin
- -59.61%
- Debt/Equity Ratio
- 47.9%
Shanghai Junshi Biosciences Co., Ltd. Competitors
About 1877
- Founded
- 2012
- Employees
- 2578
- CEO
- WebsiteView website
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.
Chinese Market Performance
- 7 Days: -1.1%
- 3 Months: 11.1%
- 1 Year: 28.8%
- Year to Date: 11.5%
Over the last 7 days, the market has dropped 1.1%, driven by a decline of 2.4% in the Industrials sector. As for the longer term, the market has actually risen by 29% in the last year. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading